skip to main content
Show Results with:

Results 11 - 20 of 50  for Everything in this catalogue

previous page 1 results 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
11
Material Type:
Article
Add to My workspace

Pembrolizumab-associated minimal change disease in a patient with malignant pleural mesothelioma

Bickel, Angelika et al.

BMC cancer. Volume 16:Issue 1 (2016); pp 1-3 -- BioMed Central

Online access

12
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist. Volume 22:Number 7 (2017, July); pp 782-e70 -- AlphaMed Press

Online access

13
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist. Volume 22:Number 7 (2017, July); pp 782-e70 -- AlphaMed Press

Online access

14
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist -- AlphaMed Press -- Volume: 22 Issue: 7; (pages 782-783) -- 2017

Check library holdings

15
Material Type:
Article
Add to My workspace

Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

Siano, Marco et al.

The oncologist. Volume 22:Number 7 (2017, July); pp 782-e70 -- AlphaMed Press

Online access

16
Material Type:
Article
Add to My workspace

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111 (2017); pp 176-181 -- Elsevier Science Pub. Co

Online access

17
Material Type:
Article
Add to My workspace

Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab

Diem, Stefan et al.

Lung cancer. Volume 111: (2017, September); pp 176-181 -- Elsevier Science Pub. Co

Online access

18
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107 (2019); pp 8-14 -- Elsevier

Online access

19
Material Type:
Article
Add to My workspace

Characterization of nivolumab-associated skin reactions in patients with metastatic non-small cell lung cancer

Hasan Ali, Omar et al.

Oncoimmunology. Volume 5:Number 11 (2016) -- Taylor & Francis

Online access

20
Material Type:
Article
Add to My workspace

Human leukocyte antigen variation is associated with adverse events of checkpoint inhibitors

Hasan Ali, Omar et al.

European journal of cancer. Volume 107: (2019, January); pp 8-14 -- Elsevier

Online access

Results 11 - 20 of 50  for Everything in this catalogue

previous page 1 results 2 3 4 5 next page

Refine Search Results

Refine my results

Access Options 

  1. Request to Reading Room  (39)
  2. Online: Reading Room only  (28)
  3. Purchase a copy  (25)
  4. Refine further open sub menu

Material type 

  1. Articles  (46)
  2. Books  (3)
  3. Audio  (1)
  4. Refine further open sub menu

Creation date 

From To
  1. Before2007  (2)
  2. 2007To2013  (3)
  3. 2014To2015  (10)
  4. 2016To2018  (23)
  5. After 2018  (11)
  6. Refine further open sub menu

Language 

  1. German  (3)
  2. English  (2)
  3. Refine further open sub menu

Additional Features 

  1. Abstract  (36)
  2. No Abstract  (10)
  3. Refine further open sub menu

Try a new search

Ignore my search and look for everything

by this Author/Contributor:

  1. Früh, Martin
  2. Peters, Solange
  3. Gautschi, Oliver
  4. Glatzer, Markus
  5. Flatz, Lukas

Searching Remote Databases, Please Wait